LEO Pharma Delivers 8% Revenue Growth at CER in 9M 2025 and Updates Full-Year Outlook
BALLERUP, Denmark–(BUSINESS WIRE)–In the first nine months of 2025, LEO Pharma continued its robust revenue growth, with significantly improved profitability... Read more.
4most and VB Risk Advisory Join Forces to Accelerate Growth of Their Risk Advisory Services in Northern Europe
VB’s commitment to grass roots talent and their people-centric culture combined with continued delivery excellence has allowed it to become an established,... Read more.
Red Hat Introduces Confirmed Sovereign Support for European Union
Dedicated, EU-citizen-driven support delivers localized operational control and resilience for digital sovereignty PARIS–(BUSINESS WIRE)–Red Hat, the... Read more.
UMC Reports Sales for October 2025
TAIPEI, Taiwan–(BUSINESS WIRE)–United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”) today reported unaudited net sales for the month... Read more.
Circus Defence Signs Strategic Agreement with Ukraine’s Government Defence Program BRAVE1 and MITS
Ukraine among first forces to roll out Circus AI robotics systems – deployments of AI-powered autonomous nutrition supply systems to begin immediately. Circus... Read more.
Phoenix Group Launches 30MW Hydropower Mining Operation in Ethiopia; H.C. Wainwright Reaffirms Buy Rating and AED 3.00 Price Target
Announces the latest energization of the 30MW hydropower operation in Ethiopia Developed in partnership with Ethiopian Electric Power (EEP) under Abu Dhabi leadership... Read more.
William Whittington Becomes Global Head of Specialty Credit & Mid Term at Allianz Trade
PARIS–(BUSINESS WIRE)–Allianz Trade, the world leader in trade credit insurance, today announces a change in management within its Specialty Credit &... Read more.
Checkmarx One Achieves ACN Level 2 Certification, Setting a New Standard for Software Security and Digital Sovereignty in Italy
MILAN–(BUSINESS WIRE)–Checkmarx, the leader in cloud-native, agentic application security for enterprises, has officially achieved Level 2 certification... Read more.
Samsung Bioepis Reaches Settlement Agreement for PYZCHIVA® (ustekinumab) in Europe
INCHEON, Korea–(BUSINESS WIRE)–#biosimilars–Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Johnson & Johnson... Read more.
SES Delivers Solid 9 Months and Q3 2025 Results
LUXEMBOURG–(BUSINESS WIRE)–SES S.A. fully consolidates Intelsat from 17 July 2025 and announces financial results for the nine months and three months... Read more.